Top Markets
Coin of the day
Australian Clinical Labs Limited Australian Clinical Labs Limited

Australian Clinical Labs Limited

ACL
Rank in Stocks #15163
Australian Clinical Labs Limited operates across Australia, delivering a... Australian Clinical Labs Limited operates across Australia, delivering a diverse range of diagnostic pathology services. The company's extensive portfolio encompasses standard examinations alongside advanced molecular genetics, including Harmony NIPT and initial trimester screenings, as well as genetic carrier screening. Furthermore, it provides detailed analyses in chemical, tissue (histopathology), and cellular (cytopathology) pathology; specialized tests for hematology, allergies, and immunology; and comprehensive serology and microbiology services. ACL also performs infectious molecular testing, cardiac diagnostic assessments, functional pathology, veterinary pathology, and commercial drug and alcohol screening. These essential services are supplied to both private and public hospitals throughout the nation. The company was founded in 2020 and maintains its primary operational base in Clayton, Australia.
Share Price
$1.98
Market Cap
$368.99M
Change (1 day)
0.90%
Change (1 year)
11.38%
Country
AU
Trade Australian Clinical Labs Limited (ACL)

Category

Stock price history for Australian Clinical Labs Limited (ACL)
Highest end of day price: $1.98 on 2026-09-01

Lowest end of day price: $2.77 on 2021-05-01
Stock price history of Australian Clinical Labs Limited from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -11.37%
2025 -17.41%
2024 18.72%
2023 -9.09%
2022 -42.56%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$618.84 25.60%
US
$213.90 3.93%
US
$22.13 41.40%
CN
$319.66 89.99%
US
$557.63 -13.82%
US